Article Details

PFIZER Clostridium difficile Vaccine did not meet primary endpoints: PHASE 3 CLOVER Trial

Retrieved on: 2022-03-06 07:59:15

Tags for this article:

Click the tags to see associated articles and topics

PFIZER Clostridium difficile Vaccine did not meet primary endpoints: PHASE 3 CLOVER Trial. View article details on hiswai:

Excerpt

New York: Pfizer Inc. announced results from the CLOVER trial (CLOstridium difficile Vaccine Efficacy TRial), a pivotal Phase 3 study evaluating ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up